Vaccine Market Research Reports

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines an...

The global Trivalent Flu Vaccine market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Trivalent Flu Vaccine is estimate...

The global Quadrivalent Flu Vaccine market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Quadrivalent Flu Vaccine is es...

Human diploid cell rabies vaccine is produced by human cell matrix, which has the advantages of good immune response, fast onset, good safety, and longer duration of immunity The global Human Diploid Cell Rabies Vaccine market was valued at US...

Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. The global Dendritic Cell Ca...

Clostridium vaccines are used to provide immunity against for a variety of ovine and bovine clostridial diseases such as tetanus, black disease, pulpy kidney (enterotoxaemia), and blackleg. The global Clostridium Vaccine (Animal Health) market...

Diphtheria, pertussis, and tetanus (DPT) vaccine is administered for three infectious diseases in humans-diphtheria, tetanus, and pertussis. They are administered either in childhood or middle age to produce the acquired immunity against diphtheria, ...

Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel....

The global Multivalent Pneumococcal Conjugate Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands...

The global Recombinant Novel Coronavirus Vaccine for Inhalation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the N...

Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus. The global Human Papillomavirus Vaccine market is projected to grow from US$ 2287.6 million in 2023 to US$ 2699.8 million by 202...

The Human Oral Vaccine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Huma...

The Covid-19 Vaccine market revenue was 48.74 Million USD in 2022, and will reach 9.5 Million USD in 2028, with a CAGR of -23.86% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of th...

DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of ...

The Human Papillomavirus Vaccine market revenue was 3641.25 Million USD in 2022, and will reach 5568.28 Million USD in 2028, with a CAGR of 7.34% during 2022-2028. This report elaborates the market size, market characteristics, and mar...

Enterovirus is a positive-stranded single-stranded RNA virus that is mainly parasitic in the intestine and is associated with human and mammalian diseases. The Enterovirus Vaccine market revenue was 153.7 Million USD in 2022, and will reach 39...

The PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market ...

The global Live and Attenuated Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War we...

The global Sterile Self-Disable Vaccine Syringes market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukra...

Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies. The glob...